Abstract

Key points Agents which dissolve hydroxyapatite may synergize with intravascular lithotripsy (IVL) to treat calcium plates more extensively, facilitating greater penetration of drug‐coated balloons delivered agents and maintain gain in lumen area without stenting. Dissolving hydroxyapatite could potentially allow more frequent use of high‐pressure balloons without IVL or atherectomy to fracture calcium plates, offering a lower cost approach. Other mechanisms such as debonding between calcium plate and fibrous tissue junctions may also be enhanced with IVL and calcium‐modifying agents to improve calcified vessel compliance.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.